Analyst Ratings for Sucampo Pharmaceuticals Inc. Cl A (SCMP)

Updated: 2017-07-28

An average rating of Buy has been given to Sucampo Pharmaceuticals Inc. Cl A (NASDAQ:SCMP) by analysts covering the stock. SCMP had previously received a consensus rating of Buy a month ago.

4 analysts declared SCMP a buy, 0 issued an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Many analysts weighed in on price targets for SCMP. The highest price target was 29.5, implying potential capital gains of 171.89 percent. The most pessimistic analyst gave a price target of 11, implying potential capital losses of 1.38 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -8.07 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -12.21 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

Analysts estimate earnings of SCMP to grow at a rate of 66.42 percent. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. People often look for the PEG ratio to be under 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. SCMP has a PEG ratio of 0.27.

In the trailing 52-weeks, SCMP hit 17.55 at the highest peak, while it's lowest trading point was 9.30. Today's price is 16.67 percent above the 52-week low, and below the high by 38.18 percent. SCMP has a P/E ratio of 17.79. Investors typically compare the P/E ratio to a company's peers in the industry. The SCMP value stock report compares SCMP to some of its peers using value stock charts. The stock has a market capitalization of $0.50182 billion. SCMP's next earnings release will be on 0000-00-00, which is days away.